These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 33453764)

  • 1. Effect of COVID-19 on colorectal cancer care in England.
    Turnbull C
    Lancet Gastroenterol Hepatol; 2021 Mar; 6(3):152-154. PubMed ID: 33453764
    [No Abstract]   [Full Text] [Related]  

  • 2. The impact of the first peak of the COVID-19 pandemic on colorectal cancer services in England and Wales: A national survey, by Boyle et al.
    Burns E
    Colorectal Dis; 2021 Jul; 23(7):1612. PubMed ID: 34263522
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of COVID-19 on the detection and management of colorectal cancer in England.
    Tiernan JP; Davies MM;
    Lancet Gastroenterol Hepatol; 2021 May; 6(5):342. PubMed ID: 33857442
    [No Abstract]   [Full Text] [Related]  

  • 4. How Coronavirus Disease 2019 Outbreak Is Impacting Colorectal Cancer Patients in Italy: A Long Shadow Beyond Infection.
    Pellino G; Spinelli A
    Dis Colon Rectum; 2020 Jun; 63(6):720-722. PubMed ID: 32384401
    [No Abstract]   [Full Text] [Related]  

  • 5. The impact of the COVID-19 pandemic on colorectal cancer service provision.
    CRC COVID Research Collaborative
    Br J Surg; 2020 Oct; 107(11):e521-e522. PubMed ID: 32856751
    [No Abstract]   [Full Text] [Related]  

  • 6. Considerations on Colorectal Cancer Care in a COVID-19 Pandemic Epicenter.
    Gachabayov M; Dong XD; Latifi R; Bergamaschi R
    Surg Technol Int; 2020 May; 36():148-149. PubMed ID: 32244258
    [No Abstract]   [Full Text] [Related]  

  • 7. Colorectal cancer screening in the USA in the wake of COVID-19.
    Shaukat A; Church T
    Lancet Gastroenterol Hepatol; 2020 Aug; 5(8):726-727. PubMed ID: 32569576
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of the COVID-19 pandemic on colorectal cancer care in France.
    Priou S; Lamé G; Chatellier G; Tournigand C; Kempf E
    Lancet Gastroenterol Hepatol; 2021 May; 6(5):342-343. PubMed ID: 33857441
    [No Abstract]   [Full Text] [Related]  

  • 9. Colorectal cancer services during the COVID-19 pandemic.
    CRC COVID research collaborative
    Br J Surg; 2020 Jul; 107(8):e255-e256. PubMed ID: 32441317
    [No Abstract]   [Full Text] [Related]  

  • 10. Resuming bowel cancer screening post-COVID-19.
    The Lancet Gastroenterology Hepatology
    Lancet Gastroenterol Hepatol; 2020 Aug; 5(8):711. PubMed ID: 32593321
    [No Abstract]   [Full Text] [Related]  

  • 11. Colorectal cancer referrals during the COVID-19 pandemic - a model for the faster diagnosis standard?
    Barrett K; Habib Bedwani N; Arya S; Bhargava A
    Br J Surg; 2020 Oct; 107(11):e531-e532. PubMed ID: 32871025
    [No Abstract]   [Full Text] [Related]  

  • 12. Gastrointestinal sequelae 90 days after discharge for COVID-19.
    Weng J; Li Y; Li J; Shen L; Zhu L; Liang Y; Lin X; Jiao N; Cheng S; Huang Y; Zou Y; Yan G; Zhu R; Lan P
    Lancet Gastroenterol Hepatol; 2021 May; 6(5):344-346. PubMed ID: 33711290
    [No Abstract]   [Full Text] [Related]  

  • 13. Colorectal cancer screening and the COVID-19 pandemic - Lessons learnt.
    Halloran SP
    Prev Med; 2021 Oct; 151():106539. PubMed ID: 34217407
    [No Abstract]   [Full Text] [Related]  

  • 14. The impact of the first peak of the COVID-19 pandemic on colorectal cancer services in England and Wales: A national survey.
    Boyle JM; Kuryba A; Blake HA; Aggarwal A; van der Meulen J; Walker K; Braun M; Fearnhead N
    Colorectal Dis; 2021 Jul; 23(7):1733-1744. PubMed ID: 33686679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Navigating the storm of COVID-19 for patients with suspected bowel cancer.
    D'Souza N; Abulafi M
    Br J Surg; 2020 Jun; 107(7):e204. PubMed ID: 32400893
    [No Abstract]   [Full Text] [Related]  

  • 16. Molecular-based Alternatives for Colorectal Cancer Screening during the COVID-19 Pandemic.
    Dockter AG; Angelos GC
    Surg Technol Int; 2020 May; 36():143-147. PubMed ID: 32347964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Faecal immunochemical testing in the COVID-19 era: balancing risk and costs.
    Arasaradnam RP; Bhala N; Evans C; Greenaway J; Logan R; Penman I; Seward E; Singh B; Smith S; Stephenson JA; Waugh N;
    Lancet Gastroenterol Hepatol; 2020 Aug; 5(8):717-719. PubMed ID: 32526209
    [No Abstract]   [Full Text] [Related]  

  • 18. SARS-CoV-2 pandemic: implications in the management of patients with colorectal cancer.
    Di Marzo F; Fiori E; Sartelli M; Cennamo R; Coccolini F; Catena F; Calabretto M; Riveros Cabral RJ; Lombardi M; Baiocchi GL; Cardi M; Cusi MG; Cardi M
    New Microbiol; 2020 Oct; 43(4):156-160. PubMed ID: 33021320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjusting to the COVID-19 pandemic: challenges and opportunities of frontline colorectal cancer teams in the UK.
    Aseem R; Warren O; Mills S; Smith J; Pawa N
    Int J Colorectal Dis; 2020 Sep; 35(9):1783-1785. PubMed ID: 32458396
    [No Abstract]   [Full Text] [Related]  

  • 20. ESMO management and treatment adapted recommendations in the COVID-19 era: colorectal cancer.
    Vecchione L; Stintzing S; Pentheroudakis G; Douillard JY; Lordick F
    ESMO Open; 2020 May; 5(Suppl 3):e000826. PubMed ID: 32457036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.